Equity (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

During the three months ended March 31, 2022, there were no warrants issued, exercised, or canceled. Refer to Note 10 to the consolidated financial statements within our 2021 Annual Report on Form 10-K for further discussion of the terms related to the Company’s warrants.

	Number of Warrants
	Equity  classified	Liability classified	Total	Weighted average exercise price
Outstanding at March 31, 2022	292,469	10,443,511	10,735,980	$	1.62

Schedule of Authorized Shares of Common Stock for Future Issuance

The Company has authorized shares of common stock for future issuance as follows:

	As of
	March 31, 2022	December 31, 2021
Exercise of warrants	10,735,980	10,735,980
Shares available for future stock incentive awards	7,006,788	6,039,564
Unvested restricted stock units	1,118,508	394,450
Outstanding common stock options	15,349,539	11,039,873
Total	34,210,815	28,209,867